Genotropin and Bedwetting - a phase IV clinical study of FDA data

Summary:

Bedwetting is reported as a side effect among people who take Genotropin (somatropin recombinant), especially for people who are male, 10-19 old, have been taking the drug for 1 - 6 months also take Propulsid, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Bedwetting when taking Genotropin. It is created by eHealthMe based on reports of 41,867 people who have side effects when taking Genotropin from the FDA, and is updated regularly.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.

What is Bedwetting?

Bedwetting is found to be associated with 473 drugs and 863 conditions by eHealthMe. Check the latest studies of Bedwetting.

On Jul, 21, 2026

41,867 people reported to have side effects when taking Genotropin.
Among them, 35 people (0.08%) have Bedwetting.

Among these 35 people:

How long have people been on Genotropin when they have Bedwetting? *

What is the gender of people who have Bedwetting when taking Genotropin? *

female: 9.38 %
male: 90.62 %

What is the age of people who have Bedwetting when taking Genotropin? *

What are other drugs people take besides Genotropin? *

What are other side effects people have besides Bedwetting? *

Headache (pain in head): 11 people, 31.43%
Vision Blurred: 7 people, 20.00%
Weight Increased: 4 people, 11.43%
Hemiparesis (weakness on one side of the body): 4 people, 11.43%
Diarrhea: 4 people, 11.43%
Thirst - Excessive: 4 people, 11.43%
Poor Quality Sleep: 4 people, 11.43%
Papilloedema (optic disc swelling): 3 people, 8.57%
Joint Lock: 3 people, 8.57%
Pain: 3 people, 8.57%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 5 people, 14.29%
Blood Growth Hormone Abnormal: 2 people, 5.71%
Growth Retardation (delayed growth): 2 people, 5.71%
Thyroid Diseases: 1 person, 2.86%
Endocrine Disorder (endocrine diseases are disorders of the endocrine system): 1 person, 2.86%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 2.86%
Body Height Below Normal: 1 person, 2.86%
Cardiac Disorder: 1 person, 2.86%
Coagulation Test Abnormal: 1 person, 2.86%
Dehydration (dryness resulting from the removal of water): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Genotropin and have Bedwetting?

- Check whether Bedwetting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Genotropin:

Genotropin (41,924 reports)

Bedwetting treatments and more:

Bedwetting (6,093 reports)

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bedwetting:

Bedwetting (473 drugs)

Browse all the conditions that are associated with Bedwetting:

Bedwetting (863 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Genotropin) and Genotropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.